**12. References**


Brakenhielm E., Cao R., Gao B., et al. (2004). Angiogenesis inhibitor, TNP-470, prevents diet-

Brakenhielm E. & Cao Y. (2008). Angiogenesis in adipose tissue. *Methods Mol Biol*, 456, pp.

Cannon B. & Nedergaard J. (2004). Brown adipose tissue: function and physiological

Cao R., Brakenhielm E., Pawliuk R., et al. (2003). Angiogenic synergism, vascular stability

Cao R., Bjorndahl M., Religa, P., et al. (2004). PDGF-BB induces intratumoral

Cao R., Eriksson E., Kubo H., et al. (2004). Comparative evaluation of FGF-2-, VEGF-A-, and

Cao R., Jensen LD, Soll I., et al. (2008). Hypoxia-induced retinal angiogenesis in zebrafish as

Cao Y. (2005). Emerging mechanisms of tumour lymphangiogenesis and lymphatic

Cao Y., Hong A., Schulten H., et al. (2005). Update on therapeutic neovascularization.

Cao Y. (2007). Angiogenesis modulates adipogenesis and obesity*. J Clin Invest*, 117, 9, pp.

Cao Y. (2008). Molecular mechanisms and therapeutic development of angiogenesis

Cao Y. (2008). Why and how do tumors stimulate lymphangiogenesis?. *Lymphat Res Biol,* 6

Cao Y. (2010). Therapeutic angiogenesis for ischemic disorders: what is missing for clinical

Cao, Y. (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic

Cao Z., Jensen LD., Rouhi P., et al. (2010). Hypoxia-induced retinopathy model in adult

Carmeliet P., Ferreira V., Breier G., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. *Nature*, 380, 6573, pp. 435-9 Cypess AM., Lehman S., Williams G., et al. (2009). Identification and importance of brown adipose tissue in adult humans. *New Engl. J Med*, 360, 15, pp. 1509-17 Dahl Ejby Jensen L., Cao R., Hedlund EM., et al. (2009). Nitric oxide permits hypoxia-

Davis GE. & Senger DR. (2005). Endothelial extracellular matrix biosynthesis, remodeling,

Eriksson A., Cao R., Pawliuk R., et al. (2002). Placenta growth factor-1 antagonizes VEGF-

induced lyphatic perfusion by controlling arterial-lymphatic conduits in zebrafish

and functions during vascular morphogenesis and neovessel stabilization. *Circ. Res*,

induced angiogenesis and tumor growth by the formation of functionally inactive

Carmeliet P. (2003). Angiogenesis in health and disease. *Nat. Med*, 9, 6, pp. 653-60

and glass catfish. *Proc Natl. Acad. Sci. U S A*, 106, 43, pp. 18408-13

PlGF-1/VEGF heterodimers. *Cancer Cell*, 1, 1, pp- 99-108

and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.

lymphangiogenesis and promotes lymphatic metastasis. *Cancer Cell*. 6, 4, pp. 333-45

VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and

induced and genetic obesity in mice*. Circ Res*, 94, 12, pp. 1579-88.

significance*. Physiol Rev*, 84, 1, pp. 277-359.

permeability. *Circ. Res*, 94, 5, pp. 664-70

metastasis. *Nat. Rev. Cancer*, 5, 9, pp. 735-43

inhibitors. *Adv. Cancer Res*, 100, pp. 113-31

benefits?. *Discov. Med*, 9, 46, pp. 179-84

zebrafish. *Nat. Protoc*, 5, 12, pp. 1903-10

diseases. *Nat Rev Drug Discov*, 9, 2, pp. 107-15.

*Cardiovasc Res*, 65, 3, pp. 639-48

a model to study retinopathy. *PLoS ONE*, 3, 7, pp. e2748

*Nat. Med*, 9, 5, pp. 604-13

65-81

2362-8.

,3-4, pp. 145-8

97, 11, pp. 1093-107

